SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-100000
Filing Date
2017-03-28
Accepted
2017-03-28 17:23:02
Documents
5
Effectiveness Date
2017-03-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A d364817ddefa14a.htm DEFA14A 16903
2 GRAPHIC g364817img01.jpg GRAPHIC 75722
3 GRAPHIC g364817img02.jpg GRAPHIC 144145
4 GRAPHIC g364817img03.jpg GRAPHIC 35875
5 GRAPHIC g364817img04.jpg GRAPHIC 7002
  Complete submission text file 0001193125-17-100000.txt   370972
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36327 | Film No.: 17719917
SIC: 2834 Pharmaceutical Preparations